235 related articles for article (PubMed ID: 17545786)
1. Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer.
Siersema PD
Curr Opin Gastroenterol; 2007 Jul; 23(4):456-61. PubMed ID: 17545786
[TBL] [Abstract][Full Text] [Related]
2. Staging and treatment of advanced esophageal cancer.
von Rahden BH; Stein HJ
Curr Opin Gastroenterol; 2005 Jul; 21(4):472-7. PubMed ID: 15930991
[TBL] [Abstract][Full Text] [Related]
3. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
4. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
Siersema PD; van Hillegersberg R
Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
[TBL] [Abstract][Full Text] [Related]
5. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
6. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
[TBL] [Abstract][Full Text] [Related]
7. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM
Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963
[TBL] [Abstract][Full Text] [Related]
8. Impact of fluorodeoxyglucose PET on the management of esophageal cancer.
Salavati A; Basu S; Heidari P; Alavi A
Nucl Med Commun; 2009 Feb; 30(2):95-116. PubMed ID: 19194210
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
[TBL] [Abstract][Full Text] [Related]
11. [Epidermoid cancer of the esophagus: overview].
Arlettaz Y; Clavien PA; Sappino PA; Spiliopoulos A; Mégevand R
Schweiz Med Wochenschr; 1990 Mar; 120(10):325-34. PubMed ID: 1690444
[TBL] [Abstract][Full Text] [Related]
12. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Mariette C; Piessen G; Briez N; Triboulet JP
Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
[TBL] [Abstract][Full Text] [Related]
13. Esophageal cancer: diagnosis and treatment.
Viswanathan V; Fleischer D
Gastroenterologist; 1995 Mar; 3(1):3-13. PubMed ID: 7538015
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
Duong C; Greenawalt DM; Kowalczyk A; Ciavarella ML; Raskutti G; Murray WK; Phillips WA; Thomas RJ
Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic endoscopy.
Kuipers EJ; Haringsma J
J Surg Oncol; 2005 Dec; 92(3):203-9. PubMed ID: 16299782
[TBL] [Abstract][Full Text] [Related]
16. New developments in palliative therapy.
Siersema PD
Best Pract Res Clin Gastroenterol; 2006; 20(5):959-78. PubMed ID: 16997172
[TBL] [Abstract][Full Text] [Related]
17. Palliative therapy.
Homs MY; Kuipers EJ; Siersema PD
J Surg Oncol; 2005 Dec; 92(3):246-56. PubMed ID: 16299791
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
[TBL] [Abstract][Full Text] [Related]
20. Palliation of malignant dysphagia in esophageal cancer: a literature-based review.
Javle M; Ailawadhi S; Yang GY; Nwogu CE; Schiff MD; Nava HR
J Support Oncol; 2006 Sep; 4(8):365-73, 379. PubMed ID: 17004508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
